Deals

InnoCare Strikes Strategic Research and Licensing Deal With Eli Lilly – Up to USD 100 Million Upfront and USD 3.25 Billion in Milestones for Up to Five Innovative Target Programs
Eli LillyHKG: 9969

InnoCare Strikes Strategic Research and Licensing Deal With Eli Lilly – Up to USD 100 Million Upfront and USD 3.25 Billion in Milestones for Up to Five Innovative Target Programs

InnoCare Pharma Limited (HKG: 9969; SHA: 688428) announced that it has entered into a strategic research, development, and licensing agreement with Eli Lilly and Company (NYSE: LLY) to develop innovative…

Sanyou Bio and NovoCodex Forge Strategic ADC Partnership – AI‑Driven Antibody Discovery Meets Site‑Specific Conjugation for Dual‑Targeting, Dual‑Payload Programs

Sanyou Bio and NovoCodex Forge Strategic ADC Partnership – AI‑Driven Antibody Discovery Meets Site‑Specific Conjugation for Dual‑Targeting, Dual‑Payload Programs

Shanghai RAAS to Acquire 100% of Boehringer Ingelheim China Investment Entity for Up to RMB 20 Million – Deal Secures End‑to‑End In‑House Control of First‑in‑Class SR604 Injection

Shanghai RAAS to Acquire 100% of Boehringer Ingelheim China Investment Entity for Up to RMB 20 Million – Deal Secures End‑to‑End In‑House Control of First‑in‑Class SR604 Injection

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
AbbVie Licenses IGI Therapeutics' ISB 2001 for Oncology and Autoimmune Diseases
AbbVieIGI Therapeutics

AbbVie Licenses IGI Therapeutics’ ISB 2001 for Oncology and Autoimmune Diseases

JCR Pharmaceuticals Signs Licensing Agreement with AstraZeneca's Alexion for JUST-AAV Gene Therapy Platform
AstraZenecaJCR Pharmaceuticals

JCR Pharmaceuticals Signs Licensing Agreement with AstraZeneca’s Alexion for JUST-AAV Gene Therapy Platform

Biocytogen and BeOne Medicines Deepen Partnership with Global Antibody Licensing Agreement
BeOne MedicinesBiocytogen Pharmaceuticals

Biocytogen and BeOne Medicines Deepen Partnership with Global Antibody Licensing Agreement

Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs
NovartisNYSE: NVS

Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs

Show More